Bill tracker, H.R. 5160, Health

Stem Cell Therapeutic and Research Reauthorization Act of 2025

  1. Introduced
  2. In committee
  3. Reported
  4. Passed the House
  5. Passed the Senate
  6. To the President
  7. Became law

Introduced Sep 4, 2025 with 21 cosponsors. Latest action Jul 21, 2026: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

Sponsor

Committees

Timeline

CommitteeHouseSenatePresidentOctNovDec2026FebMarAprMayJunJulSep 4, 2025: Introduced in HouseSep 4, 2025: Referred to the House Committee on Energy and Commerce.Sep 4, 2025: Referred to the Subcommittee on Health.May 13, 2026: Subcommittee Consideration and Mark-up Session HeldMay 13, 2026: Forwarded by Subcommittee to Full Committee by Voice Vote.May 21, 2026: Committee Consideration and Mark-up Session HeldMay 21, 2026: Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.Jul 2, 2026: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.Jul 2, 2026: Placed on the Union Calendar, Calendar No. 629.Jul 20, 2026: Mr. Guthrie moved to suspend the rules and pass the bill, as amended.Jul 20, 2026: Considered under suspension of the rules. (consideration: CR H4642-4643)Jul 20, 2026: DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.Jul 20, 2026: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)Jul 20, 2026: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)Jul 20, 2026: Motion to reconsider laid on the table Agreed to without objection.Jul 21, 2026: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
PassedFailed, tabled or vetoedBecame lawOther steps

What happened to it

Related bills

Full history

    • On the calendarSenate. Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
    • House. Motion to reconsider laid on the table Agreed to without objection.
    • House. On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
    • Passed the HousePassed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
    • House. DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
    • House. Considered under suspension of the rules. (consideration: CR H4642-4643)
    • House. Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
    • On the calendarHouse. Placed on the Union Calendar, Calendar No. 629.
    • ReportedReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
    • Committee approvedHouse. Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
    • House. Committee Consideration and Mark-up Session Held
    • HearingHouse. Forwarded by Subcommittee to Full Committee by Voice Vote.
    • HearingHouse. Subcommittee Consideration and Mark-up Session Held
    • HearingHouse. Referred to the Subcommittee on Health.
    • ReferredHouse. Referred to the House Committee on Energy and Commerce.
    • IntroducedIntroduced in House

Subjects

Biological and life sciencesBlood and blood diseasesCell biology and embryologyHealth programs administration and fundingOrgan and tissue donation and transplantation

Read the bill on Congress.gov